Diabetes & Metabolism

Papers
(The H4-Index of Diabetes & Metabolism is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
Metformin and COVID-19: From cellular mechanisms to reduced mortality140
Body mass index and outcome in patients with COVID-19: A dose–response meta-analysis104
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment100
Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials86
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients85
Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes74
A systematic review of nudge theories and strategies used to influence adult health behaviour and outcome in diabetes management66
Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes65
Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms63
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-1958
Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study56
Effects of COVID-19 pandemic lockdown on gestational diabetes mellitus: A retrospective study55
Elevated triglyceride–glucose index predicts risk of incident ischaemic stroke: The Rural Chinese cohort study48
Smoking and diabetes interplay: A comprehensive review and joint statement47
Meat and fish intake and type 2 diabetes: Dose–response meta-analysis of prospective cohort studies47
Triglyceride–glucose index associates with incident heart failure: A cohort study45
Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-1940
Is the type 2 diabetes epidemic plateauing in France? A nationwide population-based study35
Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the “Gordian Knot”?34
Fulminant type 1 diabetes after COVID-19 vaccination33
Diabetes mellitus in the era of climate change33
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies31
DPP-4 inhibition and COVID-19: From initial concerns to recent expectations31
Liraglutide and sitagliptin have no effect on intestinal microbiota composition: A 12-week randomized placebo-controlled trial in adults with type 2 diabetes29
Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction29
Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-1928
Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease26
The association between gestational diabetes mellitus and cancer in women: A systematic review and meta-analysis of observational studies26
Targeting ageing and preventing organ degeneration with metformin26
0.17687702178955